United States · FDA National Drug Code directory
Cetirizine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72476-764_46518a5f-819b-3a94-e063-6294a90a4533
- Product NDC
- 72476-764
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- RETAIL BUSINESS SERVICES,LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200421
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (72476-764-03) · 72476-764-03
- 14 TABLET in 1 BLISTER PACK (72476-764-16) · 72476-764-16
- 120 TABLET in 1 BOTTLE (72476-764-23) · 72476-764-23
- 70 TABLET in 1 BOTTLE (72476-764-70) · 72476-764-70
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →